Nonn, O; Debnath, O; Valdes, DS; Fischer, C; Secener, K; Tiesmeyer, S; Ishaque, N; Sallinger, K; El-Heliebi, A; Staff, A; Dominik, NM; Dechend, R; Gauster, M; Herse, F
Unravelling Cell-specific Interactions At The Preeclamptic Maternal-foetal Interface From Early To Late Pregnancy
HYPERTENSION. 2021; 78:
Doi: 10.1161/hyp.78.suppl_1.27
[Onlinepräsentation]
Web of Science
FullText
FullText_MUG
Fischer, C; Hofmann, M; Hofer, K; Kaar, J; Bartl, I; Gabriel, C
Hepatitis E exposure in blood donors in upper Austria
Transfusion Medicine and Hemotherapy. 2014; 41(Suppl ):66-66.-47. Jahrestagung der Deutschen Gesellschaft für Transfusionsmedizin und Immunhämatologie; Spe 9-12 2014; Dresden, Deutschland. (ISBN: 1660-3796 )
[Poster]
FullText
Fischer, C; Leithner K; Wohlkoenig, C; Quehenberger, F; Bertsch A; Olschewski O, Olschewski, A; Hrzenjak, A
Reduction of hypoxia-induced cisplatin resistance of NSCLC cells via HIF-1alpha destabilization
Forschungsfeld Krebsforschung Mitgliederversammlung; SEPT 22, 2014; Graz, AUSTRIA. 2014.
[Oral Communication]
Hrzenjak, A; Fischer, C; Leithner, K; Wohlkoenig, C; Quehenberger, F; Olschewski, A; Olschewski, H
Panobinostat reduces hypoxia-related cisplatin resistance of non-small cell lung carcinoma cells via HIF-1alpha destabilization
European Journal of Cancer. 2014; 50 Supplement 5: S203-S203.-23rd Biennial Congress of the European Association for Cancer Research; JULY 5-8, 2014; Munich, Germany.
[Poster]
Hrzenjak, A; Fischer, C; Leithner, K; Wohlkoenig, C; Quehenberger, F; Olschewski, A; Olschewski, H
Panobinostat reduces hypoxia-related cisplatin resistance of non-small cell lung carcinoma cells via HIF-1alpha destabilization.
EUR J CANCER. 2014; 50: S203-S204.
Doi: 10.1016/S0959-8049(14)50741-1
[Poster]
Web of Science
FullText
FullText_MUG
Scheipl, S; Fischer, C; Zopf, A; Deutsch, A; Jorgensen, M; Carvalho, D; Lohberger, B; Froehlich, EV; Leithner, A; Liegl, B; Rinner, B
Mutation analysis of nine chordoma specimens by targeted next generation cancer panel sequencing
VIRCHOWS ARCH. 2014; 465: S326-S326.
[Poster]
Web of Science
Fischer, C; Danzer, M; Hofer, K; Bartl, I; Böhm, S; Kaar,J; Tobisch, B; Gabriel C
Prevalence of CMV-PCR positive platelet donors without antibodies in Upper Austria
Transfusion medicine and hemotherapy. 2013; 40(Suppl):53-53.-46. Jahrestagung der Deutschen Gesellschaft für Transfusionsmedizin und Immunhämatologie; Sep 24-29 2013; Münster, Deutschland. (ISBN: 1660-3796 )
[Poster]
FullText
Rinner, B; Weinhaeusel, A; Lohberger, B; Froehlich, EV; Pulverer, W; Fischer, C; Meditz, K; Scheipl, S; Trajanoski, S; Guelly, C; Leithner, A; Liegl; B
DNA Methylation markers in chordoma cancer.
Fourth International Chordoma Research Workshop; MAR 21-22, 2013; Boston, MA. 2013.
[Oral Communication]
Rinner, B; Froehlich, EV; Buerger, K; Lohberger, B; Scheipl, S; Fischer, C; Leithner, A; Guelly, C; Trajanoski, S; Karoly, S; Liegl, B
Establishment and detailed functional and molecular genetic characterisation of a novel sacral chordoma cell line: MUG-Chor1.
EuroBoNeT abstracts; Poster presentations RL2.. 2011; -EuroBoNeT Meeting; JAN 11, 2011; Paris, FRANCE.
[Poster]
Rinner, B; Fröhlich, EV; Bürger, K; Lohberger, B; Scheipl, S; Fischer, C; Leithner, A; Gülly, C; Trajanoski, S; Szuhai, K; Liegl-Atzwanger, B
Establishment and detailed characterisation of a novel sacral chordoma cell line: MUG-Chor1.
Abstracts of the 3rd International Chordoma Research Workshop. 2011; -Third International Chordoma Research Workshop; MAR 17-19, 2011; Bethesda, Maryland - UNITED STATES.
[Oral Communication]
Weger, M; Gülly, C; Fischer, C; Haas, A; Barounig, A; Wedrich, A; El-Shabrawi, Y
Die Bedeutung von CCR3 Genpolymorphismen als Risikofaktoren für die exsudative altersabhängige Makuladegeneration
Spektrum der Augenheilkunde 2010; 24(2):105-106.-Jahrestagung der Österreichischen Ophthalmologischen Gesellschaft; Mai 13-15, 2010; Zell am See .
[Oral Communication]
Auer-Grumbach, M; Fischer, C; Duong, N; Huebner, A; John, E; Wagner, K; Speicher, M; Wehnert, M
LMNA p.R644C: Pathogenic mutation of low penetrance, disease modifier or polymorphism?
NEUROMUSCULAR DISORD. 2007; 17(9-10):799-799.
Doi: 10.1016/j.nmd.2007.06.129
[Poster]
Web of Science
FullText
FullText_MUG
Auer-Grumbach, M; John, E; Wallefeld, W; Fischer, C; Speicher, M; Laing, N
A novel slow-skeletal myosin (MYH7) mutation in a large Austrian family presenting as late onset distal myopathy
NEUROMUSCULAR DISORD. 2007; 17(9-10):883-884.
Doi: 10.1016/j.nmd.2007.06.407
[Poster]
Web of Science
FullText
FullText_MUG